Schizophrenia and Disorders with Psychotic Features  >>  Invega Sustenna (paliperidone palmitate extended-release 1-month injection) 
Welcome,         Profile    Billing    Logout  

2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Invega Sustenna (paliperidone palmitate extended-release 1-month injection) / J&J
NCT01458379: Brain Myelination Effects of Paliperidone Palmitate Versus Oral Risperidone in First Episode Schizophrenia

Not yet recruiting
4
50
US
Paliperidone Palmitate, Risperidone
University of California, Los Angeles, Ortho-McNeil Janssen Scientific Affairs, LLC
Schizophrenia
10/14
12/15
NCT01359293: Effects of Paliperidone Palmitate Versus Oral Antipsychotics on Clinical Outcomes and MRI Measures

Recruiting
N/A
120
US
paliperidone palmitate, Sustenna, oral antipsychotics
University of Iowa, Wishard Health Services
Schizophrenia, Schizophreniform
04/14
12/14

Download Options